Additionally, some of the participants actually experienced a worsening of the Parkinsons symptoms that were then alleviated upon stopping the NAC supplementation
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
Cao H et al., 2021
| DOI: 10.4103/iju.IJU_15_17 Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F
While the mechanism of action for BPC-157 is still unclear, it is believed to entail the upregulation of growth factors, the modulation of nitric oxide (NO) synthesis, and the control of functions of collagen fragments that are associated with bone morphogenic proteins [1]
Brzoska T, Luger TA, Maaser C, Abels C, Bohm M